id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
yDJdjMMmEem-1SdYy6Tusg,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD8,s been recently associated with ,+ T-cell dysfunction during HIV ,TextQuoteSelector,TextPositionSelector,17391,17394,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:44:54.333643+00:00
y2Ol-sMnEemc9keiFHXWbA,jgraPEon,https://europepmc.org/articles/PMC4944956/,PE,"323, Biolegend#302828) and CCR7-","-Cy7 (clone 3D12, BD#557648). Th",TextQuoteSelector,TextPositionSelector,19944,19946,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:52:09.234699+00:00
x2HnwMu9EemFWnNmB8Lbcw,jgraPEon,https://europepmc.org/articles/PMC4944956/,"LAG-3 and PD-1 are commonly co-expressed on exhausted or dysfunctional T cells in models of chronic infections [45], autoimmune diseases [46], and cancers","ampen T cell functions. Indeed, "," [47,48]. Potential synergistic ",TextQuoteSelector,TextPositionSelector,48876,49030,YGD,no,YGD,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:05:56.367248+00:00
tyDcRMMmEemO2--laxFDIg,jgraPEon,https://europepmc.org/articles/PMC4944956/,IL-10, decreasing IL-12 and enhancing , productions [23]. TIGIT has bee,TextQuoteSelector,TextPositionSelector,17327,17332,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:44:25.798955+00:00
tunQjsMpEem_F5M4aPuSjA,jgraPEon,https://europepmc.org/articles/PMC4944956/,TIGIT,o 1.75)0.1181.32 (0.93â€“1.88)0.12, single +1.06 (0.99 to 1.14)0.10,TextQuoteSelector,TextPositionSelector,34284,34289,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:05:53.765307+00:00
tdzxFMMnEemt1IMtV77FMQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,CCR7,"one O323, Biolegend#302828) and ","-PE-Cy7 (clone 3D12, BD#557648).",TextQuoteSelector,TextPositionSelector,19939,19943,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:51:33.107479+00:00
t6jeOMu9EemELgfzgZXQkg,jgraPEon,https://europepmc.org/articles/PMC4944956/,"HIV infection, high levels of PD-1","cytokine production [18,19]. In ", are associated with T cell exha,TextQuoteSelector,TextPositionSelector,16771,16805,YGD,no,YGD,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:05:30.012375+00:00
sMbX3sMoEem1TV87__bfXQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,S1A,R as previously described [34] (, Text).The CA-US RNA was measure,TextQuoteSelector,TextPositionSelector,22115,22118,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:58:34.037623+00:00
rb9pkMMmEemSKkM9Fso2_w,jgraPEon,https://europepmc.org/articles/PMC4944956/,IL-12,"ne secretion of DCs, decreasing ", and enhancing IL-10 productions,TextQuoteSelector,TextPositionSelector,17307,17312,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:44:09.935819+00:00
r3CMWsMnEemBo6_G_Y-IaA,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD27,"PC-H7 (clone HI100, BD#560674), ","-BV650 (clone O323, Biolegend#30",TextQuoteSelector,TextPositionSelector,19893,19897,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:51:22.384663+00:00
q97C5MMfEembstdMocKrpA,jgraPEon,https://europepmc.org/articles/PMC4944956/,CXCR3,ll as cells expressing CCR6 and , show increasing contribution to,TextQuoteSelector,TextPositionSelector,15560,15565,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:54:00.415320+00:00
pcjtksMmEem-dtPfezcpCA,jgraPEon,https://europepmc.org/articles/PMC4944956/,human,own regulating proliferation of ," T cells [22], but also by modul",TextQuoteSelector,TextPositionSelector,17226,17231,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:43:56.718261+00:00
pQRGRMMnEembxC_4ixkh2A,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD45RA,"qua marker (Invitrogen#L34957), ","-APC-H7 (clone HI100, BD#560674)",TextQuoteSelector,TextPositionSelector,19853,19859,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:51:04.907803+00:00
pJ3v0sMfEem1Pse8Th7KHg,jgraPEon,https://europepmc.org/articles/PMC4944956/,CCR6,lls as well as cells expressing , and CXCR3 show increasing contr,TextQuoteSelector,TextPositionSelector,15551,15555,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:53:48.111127+00:00
nfVP-MMqEemKHO_9kPCjIA,jgraPEon,https://europepmc.org/articles/PMC4944956/,melanoma, lymphocytes from patients with , [50]. Blockages of TIGIT and PD,TextQuoteSelector,TextPositionSelector,49392,49400,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:12:21.491324+00:00
nMDGksMnEem2FYuvRhbd4w,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD19,"4-V500 (clone M5E2, BD#561391), ","-AmCyan (clone SJ25C1, BD#339190",TextQuoteSelector,TextPositionSelector,19771,19775,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:50:50.987306+00:00
n0qcjMu9Eem9J2cWBmXKpA,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD80,th outcompeting CD28 in binding ," and CD86, as well as actively d",TextQuoteSelector,TextPositionSelector,17012,17016,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:04:49.107753+00:00
m3lGYMMdEemo3pd4YYjNdw,jgraPEon,https://europepmc.org/articles/PMC4944956/,LAG-3,"o-expression of PD-1, TIGIT and ", is a marker of HIV persistence ,TextQuoteSelector,TextPositionSelector,32300,32305,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:39:13.906334+00:00
lop4YMMqEem6yJ_zVEYUSw,jgraPEon,https://europepmc.org/articles/PMC4944956/,tumor,sed with PD-1 on activated CD8+ ,-infiltrating lymphocytes from p,TextQuoteSelector,TextPositionSelector,49342,49347,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:12:09.040422+00:00
lXgcMsMnEem1Sc9LGfI2GA,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD14,"8-PB (clone RPA-T8, BD#558207), ","-V500 (clone M5E2, BD#561391), C",TextQuoteSelector,TextPositionSelector,19736,19740,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:50:38.723935+00:00
kk7vpsu9EemRj3sOLtsOgQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD160,"1, CTLA-4, LAG-3, TIGIT, TIM-3, ", and 2B4) as well as 4 markers o,TextQuoteSelector,TextPositionSelector,12090,12095,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:04:27.276967+00:00
kKy9ssMmEemUuEf0MMw1ww,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD86,peting CD28 in binding CD80 and ,", as well as actively delivering",TextQuoteSelector,TextPositionSelector,17021,17025,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:43:21.298313+00:00
kBMPDsMnEemgJ0NIJ4wwkA,jgraPEon,https://europepmc.org/articles/PMC4944956/,RPA,"vitrogen#Q10008), CD8-PB (clone ","-T8, BD#558207), CD14-V500 (clon",TextQuoteSelector,TextPositionSelector,19716,19719,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:50:29.685342+00:00
iTbb0MMmEem6v6No98Fpxw,jgraPEon,https://europepmc.org/articles/PMC4944956/,B7,"4 (CD244).PD-1, a member of the ","-CD28 superfamily, enforces an i",TextQuoteSelector,TextPositionSelector,16630,16632,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:43:08.691414+00:00
gtVFmMMqEemt4ysb9ebikg,jgraPEon,https://europepmc.org/articles/PMC4944956/,cancers,", autoimmune diseases [46], and "," [47,48]. Potential synergistic ",TextQuoteSelector,TextPositionSelector,49023,49030,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:11:35.966777+00:00
f8ncrsMnEemSXQNmbGZ8cg,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD3,one was used in the two panels: ,"-Alexa700 (clone UCHT1, BD#55794",TextQuoteSelector,TextPositionSelector,19618,19621,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:50:02.348518+00:00
evqgwMMqEemO6BNllTJZeA,jgraPEon,https://europepmc.org/articles/PMC4944956/,autoimmune diseases,"els of chronic infections [45], "," [46], and cancers [47,48]. Pote",TextQuoteSelector,TextPositionSelector,48993,49012,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:11:22.904296+00:00
djpGJsMqEemas9c0QHjpmQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,chronic infections,functional T cells in models of ," [45], autoimmune diseases [46],",TextQuoteSelector,TextPositionSelector,48968,48986,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:11:14.895051+00:00
d3A1NsMmEemlH2dDh5Dy5w,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD28 homolog,"response to ART [21]. CTLA-4, a ",", regulates the amplitude of T-c",TextQuoteSelector,TextPositionSelector,16916,16928,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:42:38.961615+00:00
c7PeVsMnEemlIpu8ZZci5Q,jgraPEon,https://europepmc.org/articles/PMC4944956/,FWA,"(IRB #10â€“1320, Ref # 068192 and "," #00004139, respectively).Immuno",TextQuoteSelector,TextPositionSelector,19232,19235,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:49:42.173343+00:00
b2SLjsMdEemhlSvtI8-EVw,jgraPEon,https://europepmc.org/articles/PMC4944956/,LAG-3,"ells Expressing PD-1, TIGIT and ", Contribute to HIV Persistence d,TextQuoteSelector,TextPositionSelector,6407,6412,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:37:59.824127+00:00
aJVhAMMfEem-ade9VD4QUA,jgraPEon,https://europepmc.org/articles/PMC4944956/,Th1,nt reservoirs for HIV: Th17 and ,/Th17 CD4+ T cells as well as ce,TextQuoteSelector,TextPositionSelector,15501,15504,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:52:07.554236+00:00
_hRaisMTEempGB8OjP6Fyg,jgraPEon,https://europepmc.org/articles/PMC4944956/,PD-1,27415008CD4+ T Cells Expressing ,", TIGIT and LAG-3 Contribute to ",TextQuoteSelector,TextPositionSelector,6391,6395,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T06:30:24.136031+00:00
_DiYWMMmEemo91_hvRkDJg,jgraPEon,https://europepmc.org/articles/PMC4944956/,MHC-II,s to the CD4 receptor and share , as a ligand [26]. Its expressio,TextQuoteSelector,TextPositionSelector,17712,17718,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:46:21.650655+00:00
Z0VIJsMsEem527d4DIP8qw,jgraPEon,https://europepmc.org/articles/PMC4944956/,Immune Checkpoint Molecule,HIV DNA in cells expressing the , with integrated HIV DNA in cell,TextQuoteSelector,TextPositionSelector,56260,56286,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:25:08.733783+00:00
YVedEMMnEemtzWteX_5NZQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,antibody,henotyping or cell sorting. Two , panels were used to measure the,TextQuoteSelector,TextPositionSelector,19470,19478,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:49:11.382316+00:00
XGk-zMMmEemTldtk7-PFfQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,cytokine,nduced T-cell proliferation and ," production [18,19]. In HIV infe",TextQuoteSelector,TextPositionSelector,16739,16747,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:41:53.617984+00:00
Wx-d6sMmEemsyqc10A_8yg,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD28,"CD244).PD-1, a member of the B7-"," superfamily, enforces an inhibi",TextQuoteSelector,TextPositionSelector,16633,16637,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:41:51.341063+00:00
WnCdPMMqEem-g_eK5ZY-IQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,HLADR,ency of CD4+ T cells expressing ,"/CD38 (p = 0.003, r = 0.42) and ",TextQuoteSelector,TextPositionSelector,46699,46704,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:10:28.208306+00:00
W5zs5MMoEem3UesqKP_ysA,jgraPEon,https://europepmc.org/articles/PMC4944956/,FACS,ls were collected using an ARIA , sorter (Becton Dickinson).Isola,TextQuoteSelector,TextPositionSelector,21545,21549,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:56:11.126615+00:00
W512esMmEemc3-sjNL1inA,jgraPEon,https://europepmc.org/articles/PMC4944956/,TCR,ory program that blocks further ,-induced T-cell proliferation an,TextQuoteSelector,TextPositionSelector,16702,16705,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:41:52.269581+00:00
W0ZWZMMdEem1_Z_FsfNcbQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,HIV , TIGIT and LAG-3 is a marker of ,persistence during ART.(A) Frequ,TextQuoteSelector,TextPositionSelector,32321,32325,MIS_OG,yes,[MIS_OG][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:37:26.110662+00:00
V7_GjMMoEemO4cddrgCU6g,jgraPEon,https://europepmc.org/articles/PMC4944956/,ARIA,d cells were collected using an , FACS sorter (Becton Dickinson).,TextQuoteSelector,TextPositionSelector,21540,21544,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:56:04.774398+00:00
TEYmPMMqEemasrNzwHfIHA,jgraPEon,https://europepmc.org/articles/PMC4944956/,proviruses,D4+ T cells harboring inducible , during ART.Go to:DiscussionIn t,TextQuoteSelector,TextPositionSelector,44305,44315,MIS_OG,yes,[MIS_OG][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:10:04.494026+00:00
TDAbaMMfEemSSMePX4gb9w,jgraPEon,https://europepmc.org/articles/PMC4944956/,infection,d cells from which HIV reignite ,. The characterization of cell s,TextQuoteSelector,TextPositionSelector,14573,14582,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:51:19.843599+00:00
SJGF2sMrEematUc2b6bYVA,jgraPEon,https://europepmc.org/articles/PMC4944956/,HIV-1 Infection, Disease Progression in Primary ,""" in volume 12, e1005661.This ar",TextQuoteSelector,TextPositionSelector,11496,11511,"WT_OG,DS",no,[WT_OG][DS],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:17:07.779268+00:00
RdD0-sMoEemXJ7dB2yOYtw,jgraPEon,https://europepmc.org/articles/PMC4944956/,LSR,27-). Data was acquired on a BD , II flow cytometer using the FAC,TextQuoteSelector,TextPositionSelector,20967,20970,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:55:34.596629+00:00
R6GCFsMgEem5u7-9Capnmw,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD244,"in and mucin 3), CD160 and 2B4 (",").PD-1, a member of the B7-CD28 ",TextQuoteSelector,TextPositionSelector,16601,16606,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:58:21.668911+00:00
QWyTZsMnEemt0Z_vc8BwFQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,HIV-1,easured by the Abbott real time , PCR for at least 3 years. Whole,TextQuoteSelector,TextPositionSelector,18861,18866,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:48:17.725497+00:00
OjUemsMfEeman1fnvQ3x6A,jgraPEon,https://europepmc.org/articles/PMC4944956/,HIV infection, therapeutic strategies to cure ,". We identified PD-1, TIGIT and ",TextQuoteSelector,TextPositionSelector,13809,13822,"WT_OG,DS",yes,[WT_OG][DS][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:50:49.704760+00:00
OEL4GsMoEemPU0sneaS1Kw,jgraPEon,https://europepmc.org/articles/PMC4944956/,CLB,xception of CD27-QDot655 (clone ,"-27/1, Invitrogen#Q10066). In a ",TextQuoteSelector,TextPositionSelector,21333,21336,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:55:11.797498+00:00
NTwZtMMrEemPX6sl0Kfgwg,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD38,f CD4+ T cells expressing HLADR/," (p = 0.003, r = 0.42) and Ki67 ",TextQuoteSelector,TextPositionSelector,46705,46709,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:16:35.281818+00:00
NDKH8MMdEem1NBdL-s3P7Q,jgraPEon,https://europepmc.org/articles/PMC4944956/,HIV,", TIGIT and LAG-3 Contribute to ", Persistence during ARTRÃ©mi From,TextQuoteSelector,TextPositionSelector,6427,6430,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:36:20.570573+00:00
N26bjsMsEemgMO_kJOZSwA,jgraPEon,https://europepmc.org/articles/PMC4944956/,ICs,2].Immune checkpoint molecules (,) are co-inhibitory receptors wh,TextQuoteSelector,TextPositionSelector,15676,15679,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:23:48.458155+00:00
N0XWQsMgEemO05_sSIsjTA,jgraPEon,https://europepmc.org/articles/PMC4944956/,T cell immunoglobulin and mucin 3,"obulin and ITIM domain), TIM-3 (","), CD160 and 2B4 (CD244).PD-1, a",TextQuoteSelector,TextPositionSelector,16550,16583,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:57:54.223464+00:00
MePcYsMgEem3qfcDy8WGyg,jgraPEon,https://europepmc.org/articles/PMC4944956/,T-cell immunoglobulin and ITIM domain,"cyte activation gene 3), TIGIT (","), TIM-3 (T cell immunoglobulin ",TextQuoteSelector,TextPositionSelector,16503,16540,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:57:45.196705+00:00
MA_iwMMeEemLcFOux9UxgA,jgraPEon,https://europepmc.org/articles/PMC4944956/,2B4," LAG-3, TIGIT, TIM-3, CD160 and ",) as well as 4 markers of HIV pe,TextQuoteSelector,TextPositionSelector,12100,12103,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:43:23.112862+00:00
LZFT7sMUEema3NfNTdvB1A,jgraPEon,https://europepmc.org/articles/PMC4944956/,TIGIT,"08CD4+ T Cells Expressing PD-1, ", and LAG-3 Contribute to HIV Per,TextQuoteSelector,TextPositionSelector,6397,6402,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T06:31:43.978786+00:00
K_HjiMMnEem6wcd3AkHq6Q,jgraPEon,https://europepmc.org/articles/PMC4944956/,TNF-receptor,"r (HVEM), an atypical member of "," superfamily, delivers a co-inhi",TextQuoteSelector,TextPositionSelector,18104,18116,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:47:41.690829+00:00
KZp8PMMqEemTpAckXh22XA,jgraPEon,https://europepmc.org/articles/PMC4944956/,virus,s tested. The rate of inducible , per million cells was estimated,TextQuoteSelector,TextPositionSelector,43533,43538,MIS_OG,yes,[MIS_OG][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:09:06.357129+00:00
KJUuXsMgEemmjyNOqRyAYQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,lymphocyte activation gene 3,"e-associated protein 4), LAG-3 (","), TIGIT (T-cell immunoglobulin ",TextQuoteSelector,TextPositionSelector,16465,16493,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:57:29.588548+00:00
JlT_qsMsEem6zAv2wbJ_mQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,immune checkpoint molecules,ed that CD4+ T cells expressing , would be enriched in HIV-infect,TextQuoteSelector,TextPositionSelector,11893,11920,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:23:19.719177+00:00
JNiI_sMnEemUucdQwoD8zQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,HVEM,nd Herpes Virus Entry Mediator (,"), an atypical member of TNF-rec",TextQuoteSelector,TextPositionSelector,18075,18079,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:47:29.868528+00:00
J1DjjMMeEema90Ok99kqSA,jgraPEon,https://europepmc.org/articles/PMC4944956/,TIM-3,"es (PD-1, CTLA-4, LAG-3, TIGIT, ",", CD160 and 2B4) as well as 4 ma",TextQuoteSelector,TextPositionSelector,12083,12088,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:43:08.356656+00:00
IOrOtsMgEem3qNvx_KFboQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,cytotoxic T-lymphocyte-associated protein 4,"ogrammed cell death-1), CTLA-4 (","), LAG-3 (lymphocyte activation ",TextQuoteSelector,TextPositionSelector,16412,16455,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:57:16.696224+00:00
HNm-zsMUEemwgPMsccSyew,jgraPEon,https://europepmc.org/articles/PMC4944956/,PD-1,the pattern of co-expression of ,", TIGIT and LAG-3. (C), (D), (E)",TextQuoteSelector,TextPositionSelector,32818,32822,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T06:31:15.851373+00:00
HAieisMnEem5yC9pgbyNGA,jgraPEon,https://europepmc.org/articles/PMC4944956/,Herpes Virus Entry Mediator,rough its binding to its ligand ," (HVEM), an atypical member of T",TextQuoteSelector,TextPositionSelector,18046,18073,"WT_DS,GP",no,[WT_DS][GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:47:15.014942+00:00
F0X3hsMrEemc59_wIV4rKg,jgraPEon,https://europepmc.org/articles/PMC4944956/,HLA-DR,cies of CD4+ T cells expression ,"/CD38 and Ki67 respectively. P, ",TextQuoteSelector,TextPositionSelector,55312,55318,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:15:45.032499+00:00
EhUl5MMgEemgFsObfgT2mA,jgraPEon,https://europepmc.org/articles/PMC4944956/,programmed cell death-1,"analysis on 7 ICs, namely PD-1 (","), CTLA-4 (cytotoxic T-lymphocyt",TextQuoteSelector,TextPositionSelector,16378,16401,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:56:51.827464+00:00
DGMuzsMrEempy-MV8Kg1FA,jgraPEon,https://europepmc.org/articles/PMC4944956/,co-inhibitory receptors, checkpoint molecules (ICs) are , which down-modulate immune resp,TextQuoteSelector,TextPositionSelector,15685,15708,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:15:26.814672+00:00
DGIcgMMeEemc0jc9DtQmHw,jgraPEon,https://europepmc.org/articles/PMC4944956/,CTLA-4,"une checkpoint molecules (PD-1, ",", LAG-3, TIGIT, TIM-3, CD160 and",TextQuoteSelector,TextPositionSelector,12061,12067,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:42:23.268915+00:00
AdHCuMMrEemUbfcCxZ5nlw,jgraPEon,https://europepmc.org/articles/PMC4944956/,cytokines,"o improve T cell proliferation, ", production and degranulation in,TextQuoteSelector,TextPositionSelector,49478,49487,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:15:09.079901+00:00
9i0KUsMmEemPUD-B16NFpw,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD4 receptor,urally highly homologous to the , and share MHC-II as a ligand [2,TextQuoteSelector,TextPositionSelector,17689,17701,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:46:11.473644+00:00
9WGbEsMfEemctq_srlGv8g,jgraPEon,https://europepmc.org/articles/PMC4944956/,chronic viral infections,n and dysfunction in cancer and ,", including HIV [14â€“17]. We hypo",TextQuoteSelector,TextPositionSelector,16065,16089,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:56:03.565880+00:00
9-k2AMu9EemKyVNnHMIdlg,jgraPEon,https://europepmc.org/articles/PMC4944956/,TIGIT is co-expressed with PD-1 on activated CD8+ tumor-infiltrating lymphocytes from patients with melanoma,"-1 (NCT01968109). Additionally, ", [50]. Blockages of TIGIT and PD,TextQuoteSelector,TextPositionSelector,49292,49400,YGD,no,YGD,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:07:17.731929+00:00
8yUFjsMnEemH3YflVjttrQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,By55,"end#345006), CD160-AF488 (clone ",", eBioscience#53â€“1609), 2B4-PerC",TextQuoteSelector,TextPositionSelector,20251,20255,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:53:15.877782+00:00
7cXh0su9EemcEnvHyJ2lfQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,TIGIT has been recently associated with CD8+ T-cell dysfunction during HIV infection,hancing IL-10 productions [23]. , [24]. The expression of 2B4 (CD,TextQuoteSelector,TextPositionSelector,17351,17435,YGD,no,YGD,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:07:00.667931+00:00
7BhBgMMmEemhoDMF6QasfA,jgraPEon,https://europepmc.org/articles/PMC4944956/,immunoglobulin,"[17,25]. LAG-3, a member of the "," superfamily, is structurally hi",TextQuoteSelector,TextPositionSelector,17620,17634,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:45:54.595938+00:00
66s6psMfEemO0bNYSdtBcw,jgraPEon,https://europepmc.org/articles/PMC4944956/,cancer,l exhaustion and dysfunction in ," and chronic viral infections, i",TextQuoteSelector,TextPositionSelector,16054,16060,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:55:47.493417+00:00
5yAVOsMsEemgmzd_uYrTzA,jgraPEon,https://europepmc.org/articles/PMC4944956/,PD1,"I)p-valueIntegrated HIV DNA 
b

","+
1.43 (1.08 to 1.90)
0.012
1.17",TextQuoteSelector,TextPositionSelector,28212,28215,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T09:28:43.287423+00:00
4iYaGMu9EemRu_OGUcdrWA,jgraPEon,https://europepmc.org/articles/PMC4944956/,"TIGIT and PD-1 synergize to improve T cell proliferation, cytokines production and degranulation in vivo in melanoma treatment and in vitro in HIV infection",ith melanoma [50]. Blockages of ," [24,50]. All together, these st",TextQuoteSelector,TextPositionSelector,49420,49576,YGD,no,YGD,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:06:41.212989+00:00
4gpKCsMfEemHycMm5-NG_A,jgraPEon,https://europepmc.org/articles/PMC4944956/,self-tolerance,"damage, and maintain peripheral ", [13]. ICs are up regulated upon,TextQuoteSelector,TextPositionSelector,15834,15848,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T07:55:31.234012+00:00
4eScPsMoEembDqfhhFPJ5A,jgraPEon,https://europepmc.org/articles/PMC4944956/,S1B ,th those previous publications (,Text). The approach allowed us t,TextQuoteSelector,TextPositionSelector,22767,22771,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:59:56.437413+00:00
2YlAeMMmEema0cOdv636PQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,SLAM,lymphocyte activation molecule (,) is also modulated on T cells d,TextQuoteSelector,TextPositionSelector,17532,17536,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:45:23.532509+00:00
1kjiQsMmEemcwceSDBhYQQ,jgraPEon,https://europepmc.org/articles/PMC4944956/,signalling lymphocyte activation molecule,"of 2B4 (CD244), a member of the ", (SLAM) is also modulated on T c,TextQuoteSelector,TextPositionSelector,17489,17530,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:45:17.968981+00:00
0oYRnMMnEem_eLOD_BR0og,jgraPEon,https://europepmc.org/articles/PMC4944956/,antibodies,"3D12, BD#557648). The following ", were added to this backbone: PD,TextQuoteSelector,TextPositionSelector,19990,20000,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T08:52:21.168912+00:00
0cFvVsu9EemwDCOryKtxdA,jgraPEon,https://europepmc.org/articles/PMC4944956/,LAG-3 blocking mAb has recently entered clinical testing in cancer in monotherapy or in combination therapy with anti-PD-1, autoimmune diseases [49]. Anti-," (NCT01968109). Additionally, TI",TextQuoteSelector,TextPositionSelector,49140,49262,YGD,no,YGD,,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-31T07:06:13.712091+00:00
-PR3ksMTEem6kMeZHWqz3Q,jgraPEon,https://europepmc.org/articles/PMC4944956/,CD4,1PMCID: PMC4944956PMID: 27415008,"+ T Cells Expressing PD-1, TIGIT",TextQuoteSelector,TextPositionSelector,6367,6370,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"CD4 +  T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART",2019-08-20T06:30:15.623074+00:00
